Related references
Note: Only part of the references are listed.Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Drug repurposing for breast cancer therapy: Old weapon for new battle
Sadhna Aggarwal et al.
SEMINARS IN CANCER BIOLOGY (2021)
Current state and future perspective of drug repurposing in malignant glioma
Markus David Siegelin et al.
SEMINARS IN CANCER BIOLOGY (2021)
Repurposing drugs in oncology: From candidate selection to clinical adoption
Pan Pantziarka et al.
SEMINARS IN CANCER BIOLOGY (2021)
Drug repurposing for cancer therapy, easier said than done
Aurora Gonzalez-Fierro et al.
SEMINARS IN CANCER BIOLOGY (2021)
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Vinayak Palve et al.
SEMINARS IN CANCER BIOLOGY (2021)
Old drugs, new uses: Drug repurposing in hematological malignancies
Vijay P. Kale et al.
SEMINARS IN CANCER BIOLOGY (2021)
Drug databases and their contributions to drug repurposing
Yosef Masoudi-Sobhanzadeh et al.
GENOMICS (2020)
Ribavirin inhibition of cell-culture infectious hepatitis C genotype 1-3 viruses is strain-dependent
Niels Mejer et al.
VIROLOGY (2020)
Drugs for the Treatment of Zika Virus Infection
Jean A. Bernatchez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
Yue Ma-Lauer et al.
ANTIVIRAL RESEARCH (2020)
In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection
Diana Montes-Grajales et al.
ANTIVIRAL RESEARCH (2020)
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates
Vincent Madelain et al.
ANTIVIRAL RESEARCH (2020)
Cephalotaxine inhibits Zika infection by impeding viral replication and stability
Zheng-Zong Lai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities
Xiaohong Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Paolo Gelosa et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?
Paolo Gelosa et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents
Qi Chang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Next-generation drug repurposing using human genetics and network biology
Serguei Nabirotchkin et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Treatment of Ebola-related critical illness
Peter Kiiza et al.
INTENSIVE CARE MEDICINE (2020)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
Wen-Chien Ko et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Discovery and development of safe-in-man broad-spectrum antiviral agents
Petter I. Andersen et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Identification of Zika Virus NS2B-NS3 Protease Inhibitors by Structure-Based Virtual Screening and Drug Repurposing Approaches
Felipe R. S. Santos et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option
Tian-Tian Yao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Clinical trials in an Ebola outbreak seek to find an evidence-based cure
Laura K. McMullan
EBIOMEDICINE (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
New Drugs Approved in 2019
Alex M. Ebied et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses
V. M. Quintana et al.
ANTIVIRAL RESEARCH (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Repurposed drug candidates for antituberculosis therapy
Qi An et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Jacques Fantini et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
Lisi Deng et al.
JOURNAL OF INFECTION (2020)
Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
Chien-Yu Cheng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
Haiping Zhang et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
It Is Time to Address Airborne Transmission of Coronavirus Disease 2019 (COVID-19)
Lidia Morawska et al.
CLINICAL INFECTIOUS DISEASES (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
Fang Liu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
A systematic review on the ef ficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani et al.
JOURNAL OF CRITICAL CARE (2020)
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
E. Susan Amirian et al.
ONE HEALTH (2020)
Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A. Elfiky
LIFE SCIENCES (2020)
Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine
Ajay Vikram Singh et al.
ADVANCED HEALTHCARE MATERIALS (2020)
COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution
Marcelo Beltrao Molento
ONE HEALTH (2020)
Coumarin: An emerging antiviral agent
Shruti Mishra et al.
HELIYON (2020)
Inhibition of dengue virus by curcuminoids
Anuradha Balasubramanian et al.
ANTIVIRAL RESEARCH (2019)
Drug repurposing of N-acetyl cysteine as antiviral against dengue virus infection
Gopinathan Pillai Sreekanth et al.
ANTIVIRAL RESEARCH (2019)
An update on Drug Repurposing: Re-written saga of the drug's fate
Hema G. N. S. Sree et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Repurposing host-based therapeutics to control coronavirus and influenza virus
Cui-Cui Li et al.
DRUG DISCOVERY TODAY (2019)
Antimalarial drugs and their metabolites are potent Zika virus inhibitors
Yingshan Han et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Inhibition of Interleukin-1β Signaling by Anakinra Demonstrates a Critical Role of Bone Loss in Experimental Arthritogenic Alphavirus Infections
Stefan Wolf et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Zika: An Unfolding Story
Marilou Shreve et al.
JNP-JOURNAL FOR NURSE PRACTITIONERS (2019)
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review
James S. Lee et al.
BMC INFECTIOUS DISEASES (2019)
Drug repurposing for new, efficient, broad spectrum antivirals
Moises Garcia-Serradilla et al.
VIRUS RESEARCH (2019)
Strategies for Zika drug discovery
Jing Zou et al.
CURRENT OPINION IN VIROLOGY (2019)
Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses
Venice Du Pont et al.
CURRENT OPINION IN VIROLOGY (2019)
Current status of small molecule drug development for Ebola virus and other filoviruses
Megan R. Edwards et al.
CURRENT OPINION IN VIROLOGY (2019)
Antiviral activity of pinocembrin against Zika virus replication
Jia Le Lee et al.
ANTIVIRAL RESEARCH (2019)
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
Edeildo Ferreira da Silva-Junior et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Drug repurposing: a promising tool to accelerate the drug discovery process
Vineela Parvathaneni et al.
DRUG DISCOVERY TODAY (2019)
Emerging arboviruses of medical importance in the Mediterranean region
Anna Papa
JOURNAL OF CLINICAL VIROLOGY (2019)
Carnosine exhibits significant antiviral activity against Dengue and Zika virus
Hussin A. Rothan et al.
JOURNAL OF PEPTIDE SCIENCE (2019)
An extremely aggressive case of Marburg's disease treated with high dose cyclophosphamide. A case report
Jose Avila-Ornelas et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus
Shengnan Zhang et al.
ANTIVIRAL RESEARCH (2019)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
Deep learning in drug discovery: opportunities, challenges and future prospects
Antonio Lavecchia
DRUG DISCOVERY TODAY (2019)
Insights into Computational Drug Repurposing for Neurodegenerative Disease
Manish D. Paranjpe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics
Lisa Wendt et al.
ANTIVIRAL RESEARCH (2019)
Antiviral activity of ST081006 against the dengue virus
Jing Kai Lee et al.
ANTIVIRAL RESEARCH (2019)
Small molecule grp94 inhibitors block dengue and Zika virus replication
Hussin A. Rothan et al.
ANTIVIRAL RESEARCH (2019)
Improving therapy of severe infections through drug repurposing of synergistic combinations
Yu-Shan Cheng et al.
CURRENT OPINION IN PHARMACOLOGY (2019)
De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus
Emilse S. Leal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
Rajesh Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Micro-nanorobots: important considerations when developing novel drug delivery platforms
Ajay Vikram Singh et al.
Expert Opinion on Drug Delivery (2019)
A Zika Reference Panel for Molecular-Based Diagnostic Devices as a US Food and Drug Administration Response Tool to a Public Health Emergency
Mayra Garcia et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Tomatidine, a novel antiviral compound towards dengue virus
Mayra Diosa-Toro et al.
ANTIVIRAL RESEARCH (2019)
Mining of Ebola virus entry inhibitors identifies approved drugs as two-pore channel pore blockers
Christopher J. Penny et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Antiviral effects of simeprevir on multiple viruses
Zheng Li et al.
ANTIVIRAL RESEARCH (2019)
Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection
Marcus Wing Choy Loe et al.
ANTIVIRAL RESEARCH (2019)
Going Viral 2019 Zika, Chikungunya, and Dengue
Jose Dario Martinez et al.
DERMATOLOGIC CLINICS (2019)
The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions
Prasanthi Polamreddy et al.
DRUG DISCOVERY TODAY (2019)
Perspectives towards antiviral drug discovery against Ebola virus
Muhammad Usman Mirza et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Binding pattern and susceptibility of epigallocatechin gallate against envelope protein homodimer of Zika virus: A molecular dynamics study
Kowit Hengphasatporn et al.
JOURNAL OF MOLECULAR LIQUIDS (2019)
Dose Optimization of Chloroquine by Pharmacokinetic Modeling During Pregnancy for the Treatment of Zika Virus Infection
Olusola Olafuyi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine
Ilker Kudret Sariyer et al.
MOLECULAR THERAPY (2019)
Repurposing an HIV Drug for Zika Virus Therapy
Xuping Xie et al.
MOLECULAR THERAPY (2019)
Contemporary Anti-Ebola Drug Discovery Approaches and Platforms
Elena K. Schneider-Futschik et al.
ACS INFECTIOUS DISEASES (2019)
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
Luke D. Jasenosky et al.
ISCIENCE (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus
Beth Snyder et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus
Sandra L. Bixler et al.
ANTIVIRAL RESEARCH (2018)
Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment
Szu-Yuan Pu et al.
ANTIVIRAL RESEARCH (2018)
An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease
Yong Wah Tan et al.
ANTIVIRAL RESEARCH (2018)
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Min-Han Lin et al.
ANTIVIRAL RESEARCH (2018)
A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication
Priya Luthra et al.
ANTIVIRAL RESEARCH (2018)
Repurposing potential of 1st generation H-1-specific antihistamines as anti-filovirus therapeutics
Adam Schafer et al.
ANTIVIRAL RESEARCH (2018)
Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses
Lindsay Lundberg et al.
ANTIVIRAL RESEARCH (2018)
Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein
Febrina Meutiawati et al.
ANTIVIRAL RESEARCH (2018)
Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding
Baptiste Martin et al.
ANTIVIRAL RESEARCH (2018)
Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
Adrian Oo et al.
ANTIVIRAL RESEARCH (2018)
Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model
Wenjun Zhu et al.
ANTIVIRAL RESEARCH (2018)
Identification of a small molecule inhibitor of Ebola virus genome replication and transcription using in silico screening
Victoria Easton et al.
ANTIVIRAL RESEARCH (2018)
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
Annika E. Roecker et al.
ANTIVIRAL RESEARCH (2018)
Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease
Zhong Li et al.
ANTIVIRAL RESEARCH (2018)
Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens
Xiao Tong et al.
ANTIVIRAL RESEARCH (2018)
Identification of novel small-molecule inhibitors of Zika virus infection
Ewa D. Micewicz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Recent applications of machine learning in medicinal chemistry
Jane Panteleev et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
Jean-Luc Raoul et al.
CANCER TREATMENT REVIEWS (2018)
Niclosamide, a Drug with Many (Re)purposes
Hachemi Kadri et al.
CHEMMEDCHEM (2018)
The A-Z of Zika drug discovery
Melina Mottin et al.
DRUG DISCOVERY TODAY (2018)
A bibliometric review of drug repurposing
Nancy C. Baker et al.
DRUG DISCOVERY TODAY (2018)
The rise of deep learning in drug discovery
Hongming Chen et al.
DRUG DISCOVERY TODAY (2018)
The antimalarial drug amodiaquine possesses anti-ZIKA virus activities
Yingshan Han et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors
Stephen J. Capuzzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies
Shaher Bano Mirza et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Beatrice Mercorelli et al.
TRENDS IN MICROBIOLOGY (2018)
The antimicrobial peptide HS-1 inhibits dengue virus infection
Juliana M. C. Monteiro et al.
VIROLOGY (2018)
High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth
Gregory D. Bowden et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies
Satoru Watanabe et al.
ACS INFECTIOUS DISEASES (2018)
Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome(MERS): A review
Sabeena Mustafa et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2018)
High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system
Nakyung Lee et al.
ANTIVIRAL RESEARCH (2018)
Review of Drug Repositioning Approaches and Resources
Hanqing Xue et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Computational drug repurposing to predict approved and novel drug-disease associations
Zoya Khalid et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Drug repurposing of quinine as antiviral against dengue virus infection
Shilu Malakar et al.
VIRUS RESEARCH (2018)
Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition
Monika Aparecida Coronado et al.
ANTIVIRAL RESEARCH (2018)
Ezetimibe inhibits dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann-Pick C1-like 1 receptor
Juan Fidel Osuna-Ramos et al.
ANTIVIRAL RESEARCH (2018)
The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus infected A129 mice: A host-targeting treatment strategy
Jasper Fuk-Woo Chan et al.
ANTIVIRAL RESEARCH (2018)
Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease
Ankur Kumar et al.
ACS OMEGA (2018)
Anisotropic Gold Nanostructures: Optimization via in Silico Modeling for Hyperthermia
Ajay Vikram Singh et al.
ACS APPLIED NANO MATERIALS (2018)
Sofosbuvir as treatment against dengue?
Chye Sheng Gan et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2018)
Drug repurposing screens and synergistic drug-combinations for infectious diseases
Wei Zheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication
Otavio Valerio de Carvalho et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein
Nitin Sharma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Sofosbuvir: an antiviral drug with potential efficacy against Zika infection
Sandra E. Reznik et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Synthetic Approaches to the New Drugs Approved During 2015
Andrew C. Flick et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures
Anyelo Duran et al.
LIFE SCIENCES (2017)
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model
Adriaan H. de Wilde et al.
VIRUS RESEARCH (2017)
Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus
Keiko Rausch et al.
CELL REPORTS (2017)
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
Chunfeng Li et al.
EBIOMEDICINE (2017)
The FDA-approved drug sofosbuvir inhibits Zika virus infection
Kristen M. Bullard-Feibelman et al.
ANTIVIRAL RESEARCH (2017)
The natural compound silvestrol is a potent inhibitor of Ebola virus replication
Nadine Biedenkopf et al.
ANTIVIRAL RESEARCH (2017)
Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus
Anuradha Balasubramanian et al.
ANTIVIRAL RESEARCH (2017)
Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses
Jung-Sheng Yu et al.
ANTIVIRAL RESEARCH (2017)
Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus
Jared D. Pitts et al.
ANTIVIRAL RESEARCH (2017)
Cell-line dependent antiviral activity of sofosbuvir against Zika virus
Noreen Mumtaz et al.
ANTIVIRAL RESEARCH (2017)
Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice
Naganori Kamiyama et al.
ANTIVIRAL RESEARCH (2017)
Curcumin: A Review of Its Effects on Human Health
Susan J. Hewlings et al.
FOODS (2017)
Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein
Megha Aggarwal et al.
ANTIVIRAL RESEARCH (2017)
Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus
Jeng-Wei Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo
Shuofeng Yuan et al.
ANTIVIRAL RESEARCH (2017)
The medicinal chemistry of Chikungunya virus
Edeildo F. da Silva-Junior et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Polysulfonate suramin inhibits Zika virus infection
Chee Wah Tan et al.
ANTIVIRAL RESEARCH (2017)
Recent trends in ZikV research: A step away from cure
Aftab Alam et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles
Irina C. Albulescu et al.
ANTIVIRAL RESEARCH (2017)
Flex-nucleoside analogues - Novel therapeutics against filoviruses
Mary K. Yates et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies
Tao Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Chikungunya Virus
David M. Vu et al.
CLINICS IN LABORATORY MEDICINE (2017)
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding
Bryan C. Mounce et al.
ANTIVIRAL RESEARCH (2017)
Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor
Jasper Fuk-Woo Chan et al.
ANTIVIRAL RESEARCH (2017)
Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle
Baptiste Martin et al.
ANTIVIRAL RESEARCH (2017)
Activity of andrographolide against dengue virus
Patcharee Panraksa et al.
ANTIVIRAL RESEARCH (2017)
Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus
Hyun Lee et al.
ANTIVIRAL RESEARCH (2017)
Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism
Suvi Kuivanen et al.
ANTIVIRAL RESEARCH (2017)
Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay
Robert S. Adcock et al.
ANTIVIRAL RESEARCH (2017)
Small-Molecule Therapeutics for Ebola Virus (EBOV) Disease Treatment
Kunisuke Izawa et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2016)
Bioengineered and biohybrid bacteria-based systems for drug delivery
Zeinab Hosseinidoust et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
Finny S. Varghese et al.
ANTIVIRAL RESEARCH (2016)
Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo
Hussin A. Rothan et al.
ANTIVIRAL RESEARCH (2016)
Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses
Margot Carocci et al.
ANTIVIRAL RESEARCH (2016)
Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy
Satoru Watanabe et al.
ANTIVIRAL RESEARCH (2016)
Antiviral effect of ranpirnase against Ebola virus
Thomas Hodge et al.
ANTIVIRAL RESEARCH (2016)
Suramin treatment reduces chikungunya pathogenesis in mice
Szu-Cheng Kuo et al.
ANTIVIRAL RESEARCH (2016)
Antiviral activity of selected flavonoids against Chikungunya virus
Rafidah Lani et al.
ANTIVIRAL RESEARCH (2016)
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission
Yu-Ming Wang et al.
ANTIVIRAL RESEARCH (2016)
Novel antiviral activity of bromocriptine against dengue virus replication
Fumihiro Kato et al.
ANTIVIRAL RESEARCH (2016)
Teicoplanin inhibits Ebola pseudovirus infection in cell culture
Yizhuo Wang et al.
ANTIVIRAL RESEARCH (2016)
Drug repurposing of minocycline against dengue virus infection
Shilpa Lekshmi Leela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism
Rana Abdelnabi et al.
BIOCHEMICAL PHARMACOLOGY (2016)
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Nicholas J. Barrows et al.
CELL HOST & MICROBE (2016)
Adefovir dipivoxil - A possible regimen for the treatment of dengue virus (DENV) infection
Sukesh Narayan Sinha et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2016)
Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation
Kendall G. Byler et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2016)
Antiviral therapeutics for the treatment of Ebola virus infection
Anthony P. Cardile et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Discovery of antiviral molecules for dengue: In silico search and biological evaluation
Maria Cabarcas-Montalvo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Medicinal Chemistry of Dengue Virus
Mira A. M. Behnam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Drug Repositioning An Approach for Drug Discovery
Parin K. Vora et al.
MINI-REVIEWS IN ORGANIC CHEMISTRY (2016)
The green tea molecule EGCG inhibits Zika virus entry
Bruno M. Carneiro et al.
VIROLOGY (2016)
Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
Jean-Francois Rossingol
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Computational approaches in target identification and drug discovery
Theodora Katsila et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection
Christopher Weber et al.
ANTIVIRAL RESEARCH (2015)
Suramin inhibits chikungunya virus replication through multiple mechanisms
Irina C. Albulescu et al.
ANTIVIRAL RESEARCH (2015)
A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs
Jianzhong Cao et al.
ANTIVIRAL RESEARCH (2015)
Ebola virus dynamics in mice treated with favipiravir
Vincent Madelain et al.
ANTIVIRAL RESEARCH (2015)
Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A
Thidarath Rattanaburee et al.
ANTIVIRAL RESEARCH (2015)
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies
Lorena Ramos Freitas de Sousa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
HIGH DOSE FAVIPIRAVIR: FIRST EXPERIENCE IN A PATIENT WITH EBOLA
A. M. Borobia et al.
CLINICAL THERAPEUTICS (2015)
Ebola therapy: Developing new drugs or repurposing old ones?
Giovanni Lentini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Favipiravir-a prophylactic treatment for Ebola contacts?
Michel Van Herp et al.
LANCET (2015)
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
Hannah Kibuuka et al.
LANCET (2015)
Favipiravir for children with Ebola
Naim Bouazza et al.
LANCET (2015)
Development of Small-Molecule Antivirals for Ebola
Zlatko Janeba
MEDICINAL RESEARCH REVIEWS (2015)
Hierarchical virtual screening approaches in small molecule drug discovery
Ashutosh Kumar et al.
METHODS (2015)
Development of therapeutics for treatment of Ebola virus infection
Haoyang Li et al.
MICROBES AND INFECTION (2015)
Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens
Jeanne M. Sisk et al.
ACS INFECTIOUS DISEASES (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Suramin Inhibits Chikungunya Virus Entry and Transmission
Yi-Jung Ho et al.
PLOS ONE (2015)
Biomineralized Anisotropic Gold Microplate-Macrophage Interactions Reveal Frustrated Phagocytosis-like Phenomenon: A Novel Paclitaxel Drug Delivery Vehicle
Ajay Vikram Singh et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Antiviral activity of lanatoside C against dengue virus infection
Yan Yi Cheung et al.
ANTIVIRAL RESEARCH (2014)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus
Ruben Soto-Acosta et al.
ANTIVIRAL RESEARCH (2014)
Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity
Siwaporn Boonyasuppayakorn et al.
ANTIVIRAL RESEARCH (2014)
Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format
Chandrakala Basavannacharya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Ebola: Is there a hope from treatment with cardiovascular drugs?
Salvatore Patane
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Jaffar A. Al-Tawfiq et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Chikungunya Virus: Emerging Targets and New Opportunities for Medicinal Chemistry
Adel A. Rashad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
Jenny G. Low et al.
LANCET INFECTIOUS DISEASES (2014)
The long battle to find a cure for Ebola
Clare Wilson
NEW SCIENTIST (2014)
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
Javier Carbajo-Lozoya et al.
VIRUS RESEARCH (2014)
Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance
Stephanie Beaucourt et al.
CURRENT OPINION IN VIROLOGY (2014)
Antiviral drugs specific for coronaviruses in preclinical development
Adeyemi O. Adedeji et al.
CURRENT OPINION IN VIROLOGY (2014)
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus
Marcella Bassetto et al.
ANTIVIRAL RESEARCH (2013)
Ten years of dengue drug discovery: Progress and prospects
Siew Pheng Lim et al.
ANTIVIRAL RESEARCH (2013)
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Jasper F. W. Chan et al.
JOURNAL OF INFECTION (2013)
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13
Mi-Sun Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Emerging Viral Infections
James F. Bale
SEMINARS IN PEDIATRIC NEUROLOGY (2012)
Emodin inhibits current through SARS-associated coronavirus 3a protein
Silvia Schwarz et al.
ANTIVIRAL RESEARCH (2011)
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model
Abhay P. S. Rathore et al.
ANTIVIRAL RESEARCH (2011)
Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo
Jinhong Chang et al.
ANTIVIRAL RESEARCH (2011)
In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant
Ilenia Delogu et al.
ANTIVIRAL RESEARCH (2011)
Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein
Daisuke Kato et al.
ANTIVIRAL RESEARCH (2010)
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Sheng-Yong Yang
DRUG DISCOVERY TODAY (2010)
Antiviral activity of geneticin against dengue virus
Xianchao G. Zhang et al.
ANTIVIRAL RESEARCH (2009)
Homology modeling in drug discovery: current trends and applications
Claudio N. Cavasotto et al.
DRUG DISCOVERY TODAY (2009)
Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance?
Umesh C. Chaturvedi et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2009)
How To Optimize Shape-Based Virtual Screening: Choosing the Right Query and Including Chemical Information
Johannes Kirchmair et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
The Medicinal Chemistry of Dengue Fever
Andrew J. Stevens et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions
Daniel G. Bausch et al.
ANTIVIRAL RESEARCH (2008)
Molecule-pharmacophore superpositioning and pattern matching in computational drug design
Gerhard Wolber et al.
DRUG DISCOVERY TODAY (2008)
On Chikungunya Acute Infection and Chloroquine Treatment
Xavier De Lamballerie et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2008)
The search for a structural basis for therapeutic intervention against the SARS coronavirus
Bartlam Mark et al.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses
E Lee et al.
ANTIVIRAL RESEARCH (2006)
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
YC Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
M Saijo et al.
ANTIVIRAL RESEARCH (2005)
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
B Morgenstern et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Generation of predictive pharmacophore model for SARS-coronavirus main proteinase
XW Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2005)
Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase
ZM Liu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds:: synergistic effect of interferon-α and ribavirin combination
S Briolant et al.
ANTIVIRAL RESEARCH (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
N Yamamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs
XW Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
JE Blanchard et al.
CHEMISTRY & BIOLOGY (2004)
Emerging viral infections in a rapidly changing world
T Kuiken et al.
CURRENT OPINION IN BIOTECHNOLOGY (2003)
Share Paper
